X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-21 | DTIL | Kelly John Alexander | CFO | P - Purchase | $6.76 | +3,000 | 38,073 | +9% | +$20,280 | ||||||
| D | 2024-11-04 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $8.19 | -588 | 7,969 | -7% | -$4,816 | |||||
| D | 2024-11-04 | DTIL | Amoroso Michael | Pres, CEO | S - Sale+OE | $8.19 | -3,012 | 28,537 | -10% | -$24,668 | |||||
| D | 2024-06-10 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $11.79 | -93 | 6,721 | -1% | -$1,096 | |||||
| D | 2024-06-10 | DTIL | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $11.79 | -50 | 76,490 | 0% | -$590 | |||||
| D | 2024-05-02 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $10.32 | -272 | 5,680 | -5% | -$2,807 | |||||
| D | 2024-05-02 | DTIL | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $10.32 | -154 | 75,544 | 0% | -$1,589 | |||||
| D | 2024-05-02 | DTIL | List Alan | Chief Medical Officer | S - Sale+OE | $10.32 | -290 | 4,488 | -6% | -$2,993 | |||||
| D | 2024-05-02 | DTIL | Amoroso Michael | Pres, CEO | S - Sale+OE | $10.32 | -1,526 | 13,772 | -10% | -$15,748 | |||||
| D | 2024-04-30 | DTIL | List Alan | Chief Medical Officer | S - Sale+OE | $10.03 | -238 | 3,796 | -6% | -$2,386 | |||||
| D | 2024-01-22 | DTIL | Amoroso Michael | Pres, CEO | S - Sale+OE | $0.36 | -137,390 | 356,433 | -28% | -$49,460 | |||||
| D | 2024-01-22 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $0.36 | -21,287 | 151,028 | -12% | -$7,663 | |||||
| D | 2024-01-22 | DTIL | List Alan | Chief Medical Officer | S - Sale+OE | $0.36 | -21,526 | 94,982 | -18% | -$7,749 | |||||
| D | 2024-01-23 | DTIL | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $0.37 | -28,000 | 2,225,228 | -1% | -$10,360 | |||||
| D | 2023-11-03 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $0.40 | -16,023 | 112,970 | -12% | -$6,409 | |||||
| D | 2023-11-03 | DTIL | Amoroso Michael | Pres, CEO | S - Sale+OE | $0.40 | -125,025 | 227,103 | -36% | -$50,010 | |||||
| A | 2023-08-18 | DTIL | Kelly John Alexander | CFO | P - Purchase | $0.48 | +90,000 | 383,340 | +31% | +$43,200 | |||||
| D | 2023-06-08 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $0.75 | -13,361 | 68,473 | -16% | -$10,021 | |||||
| D | 2023-04-27 | DTIL | List Alan | Chief Medical Officer | S - Sale+OE | $0.79 | -7,771 | 56,496 | -12% | -$6,139 | |||||
| D | 2023-03-22 | DTIL | Amoroso Michael | Pres, CEO | S - Sale+OE | $0.82 | -46,999 | 68,738 | -41% | -$38,539 | |||||
2023-03-17 | DTIL | Kelly John Alexander | CFO | P - Purchase | $0.86 | +20,000 | 245,614 | +9% | +$17,200 | ||||||
| D | 2023-03-06 | DTIL | Scimeca Dario | GC, Secretary | S - Sale+OE | $1.07 | -12,172 | 50,063 | -20% | -$13,024 | |||||
| D | 2023-03-06 | DTIL | List Alan | Chief Medical Officer | S - Sale+OE | $1.07 | -9,473 | 38,240 | -20% | -$10,136 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |